NCT05537584View on ClinicalTrials.gov

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

August 26, 2025

Study Completion Date

August 26, 2025

Conditions
Major Depressive Disorder
Interventions
DRUG

Sertraline

Subjects will receive 8 weeks of sertraline while monitored by the study physician

DRUG

Bupropion

Subjects will receive 8 weeks of bupropion while monitored by the study physician

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER